We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

February 25, 2014

In re Solodyn (Minocycline Hydrochloride) Antitrust Litigation

Track this case

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. June 4, 2018

    End-Payor Attys Want $16M From $43M Medicis, Impax Deals

    Motley Rice LLC and Hilliard & Shadowen LLP asked a Massachusetts federal judge Friday for a one-third cut plus $1.6 million in litigation expenses from $43 million in settlements they secured from Medicis Pharmaceutical Corp. and Impax Laboratories Inc. over the allegedly delayed launch of a generic acne medicine.

17 other articles on this case. View all »

Parties

To view the parties, register now.